Early research (Phase 1)Ended earlyNCT07556757
What this trial is testing
A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia
Who this might be right for
B-ALLLeukemia
ImmunityBio, Inc. 4
Showing 20 of 0 results